Mass Spectrometry Proteomics for Drug Discovery and Development – Realizing the Promise of Precision Medicine in Oncology, Neuroscience, and Targeted Protein Degradation

It is the second issue in our series, “The New Era in Proteomics,” delving into specific applications of Mass Spectrometry for Drug Discovery and Drug Development.

Dive deep into the latest technological and scientific advances with Biognosys’ proteomics research platforms for:

• Drug Target Identification & Validation
• Biomarker Discovery & Diagnostic Development
• Precision Medicine in Key Therapeutic Areas

Join us on the innovation frontier! Download the e-book now.